IDX-17119

• Description:

  IDX-17119 is a non-nucleoside HCV NS5B RdRp inhibitor with an IC50 of 0.4 nM[1].

• UNSPSC:

  12352005

• Target:

  HCV

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Smiles:

  O=C(C1=CN(C2=CC=C(C3=NN4C(N)=CC(C)=NC4=C3)C=C2)N=C1NP(OC)(C5=CC=C(C)C=C5C)=O)O

• Molecular Formula:

  C26H26N7O4P

• Molecular Weight:

  531.50

• References & Citations:

  [1]• Manjula Saravanan, et al., The effect of genotype variation and M423 resistance mutations to the binding of phosphonomidate-based inhibitor IDX17119 with the thumb-II domain of Hepatitis C virus RdRp: an integrated molecular dynamics and binding free energy study, 2022 49 (2) :1-11.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [1987906-92-2]